Astellas-Pfizer’s combination therapy halves risk of death in bladder cancer patients
The therapy reduces tumor recurrence and death risk in bladder cancer patients
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon Biologics expands partnership with Civica to launch Insulin Glargine in the US
Biocon Biologics and Civica collaboration aims to increase access to affordable insulin in the United States
EU policy reforms and pharma investments highlight shifting industry priorities: GlobalData
GlobalData highlights how EU policy reforms and major pharma investments are reshaping industry strategies and priorities
Beyond the PDF: Why biopharma’s communication must catch up with Its science
Tamanna Khanna, Co-founder of Agram Konnect, explains why biopharma must transform communication formats to match scientific pace…
Graph AI raises $3 million seed funding to advance AI-based pharmacovigilance platform
Bessemer Venture Partners leads investment to drive innovation, global expansion, and automation in drug safety monitoring
Syngene International expands peptide and automation capabilities to accelerate drug development
New Bengaluru peptide laboratory and automation upgrades in Hyderabad aim to improve scalability, efficiency, and data quality
CPHI & PMEC India 2025 to bring global pharma leaders together in Greater Noida
18th edition of South Asia’s largest pharmaceutical event to feature 2,000+ exhibitors and 35,000+ industry professionals
Supriya Lifescience honoured with Maharashtra State Export Award for two consecutive years
Dr Satish Wagh and Dr Saloni Wagh recognised for Supriya Lifescience’s contribution to India’s pharma exports
NIT Rourkela develops eco-friendly zinc oxide nanoparticles to combat antimicrobial resistance
Researchers use medicinal plant extracts to create antibacterial agents that are scalable, environmentally safe, and effective…
Venus Remedies launches Venus Global Fulfillment Center to enhance global supply chain
The 132,000 sq ft VGFC aims to improve logistics, regulatory compliance, and timely access to medicines across over 100 countries